Smalley S R, Kimler B F, Evans R G, Dalziel W C
Department of Radiation Oncology, University of Kansas Medical Center, Kansas City 66160.
Int J Radiat Oncol Biol Phys. 1992;24(3):519-25. doi: 10.1016/0360-3016(92)91068-x.
There is ample evidence that 5-fluorouracil (5-FU) improves both local control and survival of a variety of gastrointestinal tumors when added to radiotherapy. However, the modulation of radiosensitivity by 5-FU is incompletely understood and some reports are apparently contradictory. Therefore, we have reevaluated the modulation of radiosensitivity by 5-FU in a variety of mammalian cells. HT-29 and WiDr (human colon adenocarcinoma), DU-145 (human prostate adenocarcinoma), V-79 (Chinese hamster lung fibroblast), and HeLa cell lines were maintained in exponential growth as monolayer cultures. Cell survival following treatment with drug and/or radiation was determined by colony formation assay. Radiation was delivered either alone; midway through a 1 hr exposure to 7-25 micrograms/ml 5-FU (pulse); or following initiation of 0.1-1.5 micrograms/ml 5-FU present throughout the entire incubation for assay of colony forming ability (continuous exposure). These 5-FU levels were selected to approximate those achieved in vivo in humans. The results indicate that mammalian cell lines may vary substantially insofar as modulation of their radiosensitivity by 5-FU is concerned. Radiosensitization, defined by reduction in D0, was observed for continuous exposure only in V-79, WiDr, and HT-29 cell lines, was observed for both pulse exposure and continuous exposure in DU-145, and was not present in HeLa cells. Radioenhancement, defined by reduction in n, was observed in V-79, WiDr, and HT-29 but not in the other cell lines. This effect, characterized by reduction in the shoulder portion of the curve, is naturally accompanied by a decrease of Dq. This indicates that mammalian cell lines may have different responses to radiosensitivity modulation by 5-FU. Though the cell lines may exhibit radiosensitivity by either alterations in the slope or shoulder of the cell survival curve, the mechanisms responsible for both the heterogeneity as well as the radiosensitization itself are completely unknown at this time. Insight into the mechanisms for both the heterogeneity and the radiosensitization will be important areas for further investigation.
有充分证据表明,5-氟尿嘧啶(5-FU)添加到放射治疗中时,可改善多种胃肠道肿瘤的局部控制和生存率。然而,5-FU对放射敏感性的调节作用尚未完全明确,一些报道明显相互矛盾。因此,我们重新评估了5-FU对多种哺乳动物细胞放射敏感性的调节作用。HT-29和WiDr(人结肠腺癌)、DU-145(人前列腺腺癌)、V-79(中国仓鼠肺成纤维细胞)和HeLa细胞系以单层培养的方式维持指数生长。通过集落形成试验确定药物和/或辐射处理后的细胞存活率。辐射单独进行;在1小时内中途暴露于7-25微克/毫升的5-FU(脉冲);或在整个孵育过程中加入0.1-1.5微克/毫升的5-FU后开始测定集落形成能力(持续暴露)。选择这些5-FU水平以接近人体体内达到的水平。结果表明,就5-FU对其放射敏感性的调节而言,哺乳动物细胞系可能有很大差异。仅在V-79、WiDr和HT-29细胞系中观察到持续暴露时由D0降低定义的放射增敏作用,在DU-145细胞系中观察到脉冲暴露和持续暴露时均有放射增敏作用,而HeLa细胞中未观察到。由n降低定义的放射增强作用在V-79、WiDr和HT-29细胞系中观察到,但在其他细胞系中未观察到。这种以曲线肩部降低为特征的效应自然伴随着Dq的降低。这表明哺乳动物细胞系对5-FU调节放射敏感性可能有不同反应。尽管细胞系可能通过细胞存活曲线斜率或肩部的改变表现出放射敏感性,但此时负责异质性以及放射增敏本身的机制完全未知。深入了解异质性和放射增敏的机制将是进一步研究的重要领域。